Thumbnail 1699457
thumbnail
Large (256x256)

Articles

What we still don’t know about weight-loss drugs
MIT Technology ReviewExplains: Let our writers untangle the complex, messy world of technology to help you understand what's coming next. You can readmore from the series here. Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind the drugs Mounjaro and Zepbound, became the first healthcare...
The Download: the mysteries surrounding weight-loss drugs, and the economic effects of AI
This is today's edition ofThe Download,our weekday newsletter that provides a daily dose of what's going on in the world of technology. What we still don't know about weight-loss drugs Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind Mounjaro and Zepbound, became the first...
1